While external validation in the GSE140275 bulk RNA-seq dataset showed only a nonsignificant trend toward decreased F2 expression in stroke patients, this could be attributed to factors such as the limited sample size, tissue heterogeneity, or the specific timing of sample collection poststroke.
← all excerpts
Identifying therapeutic target genes for stroke through systematic druggable Mendelian randomization analysis.
1
—
—